<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02536898</url>
  </required_header>
  <id_info>
    <org_study_id>2015/334</org_study_id>
    <nct_id>NCT02536898</nct_id>
  </id_info>
  <brief_title>Norwegian Capture the Fracture Initiative</brief_title>
  <acronym>NoFRACT</acronym>
  <official_title>Norwegian Capture the Fracture Initiative</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asker &amp; Baerum Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Drammen sykehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Molde Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim is to assess the effectiveness of introducing a standardized intervention
      program for treatment of patients with a fragility fracture as measured by changes in the
      fracture rates and the mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A fracture liaison service model of care is widely recommended but data on its effectiveness
      regarding reduced risk of recurrent fracture and fracture related mortality are scarce. The
      investigators therefore aim to assess the risk of subsequent fractures and mortality after a
      clinical fracture in patients who present to hospitals with a standardized intervention
      program. Seven Norwegian hospitals will be Stepped Wedge Cluster Randomized to a standardized
      intervention program with startup date between May 2015 and Jan 2016. The intervention will
      last throughout 2018 with follow-up throughout 2019. Outcomes before and after the
      intervention will be compared and each hospital will act as its own control. The effect of
      the intervention will be measured by using national patient registries on fractures and
      mortality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fragility fracture</measure>
    <time_frame>4 years</time_frame>
    <description>Incidence of fragility fractures per 10,000 person-years (distal forearm fractures, proximal humerus fractures and hip fractures)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>4 years</time_frame>
    <description>Total number of deaths during four years after enrollment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">87000</enrollment>
  <condition>Hip Fracture</condition>
  <condition>Vertebral Fracture</condition>
  <condition>Other Low-trauma Fracture</condition>
  <arm_group>
    <arm_group_label>Fracture liaison service</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Information, assessment &amp; lifestyle advice
refer to DXA scan, except patients with dementia, difficulties laying on the back or short life exp.
Blood samples
Sufficient intake of Vitamin D &amp; calcium, combined with physical activity will be recommended with lifestyle advice (smoking &amp; alcohol intake)
Patients With Hip, Vertebral or two or more low-trauma fractures are recommended treated with anti-osteoporosis drug
Other fractures, treatment recommended if FRAX score≥20% for major fracture &amp; T-score≤-1.5
Fracture patients with reduced kidney function will be treated with anti-RANKL
Anti-osteoporosis drug prescribed by hospital physician
Follow-up phone call after 3 months and visit to talk with coordinating nurse after 1 year
Patients with spine or femoral neck T-scores≤-3.5, &gt;2 severe vertebral fractures &amp; those who suffer a second fracture while using anti-osteoporosis drug, will be referred for further examination and teriparatide treatment will be considered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Current treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treatment as offered before intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fracture Liaison Service</intervention_name>
    <arm_group_label>Fracture liaison service</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Current treatment</intervention_name>
    <arm_group_label>Current treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Low-energy fracture

        Exclusion Criteria:

          -  finger fracture, toe fracture, face fracture, skull fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Nordsletten, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Åshild Bjørnerem, PhD</last_name>
    <phone>77660608</phone>
    <email>ashild.bjornerem@uit.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen M Apalset</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Drammen Hospital</name>
      <address>
        <city>Drammen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tove T Borgen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Molde Hospital</name>
      <address>
        <city>Molde</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens M Stutzer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lene B Solberg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bærum Hospital</name>
      <address>
        <city>Sandvika</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Langslet</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Åshild Bjørnerem</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Olavs University Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trude Basso</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2015</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Lene Bergendal Solberg</investigator_full_name>
    <investigator_title>Prof. Dr. Med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Spinal Fractures</mesh_term>
    <mesh_term>Osteoporotic Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

